United States HR 2038: State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019

Status: Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. (as of 2019-05-15)

State: United States · Session: 116 · Bill: HR 2038

Subjects: Cancer, Child health, Child safety and welfare, Congressional oversight, Drug, alcohol, tobacco use, Health care costs and insurance, Health care coverage and access, Health facilities and institutions, Health personnel, Health programs administration and funding, Long-term, rehabilitative, and terminal care, Prescription drugs, Rural conditions and development, Sales and excise taxes, State and local finance

Sponsors: Mark Meadows, Debbie Lesko, Ted Budd

View United States HR 2038 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.